Evidence map›Paper›PMID 42518160›Full record

ArticleUpdates in surgery2026

Laparoscopic surgery for T4 colon cancer: balancing oncological radicality and minimally invasive benefits.

Meng Zhao, Meiying Bai, Ming Wang

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meng ZhaoDepartment of Gastrointestinal Surgery, Heze Municipal Hospital, No. 2888 Caozhou Road, Heze, 274031, Shandong Province, China.
Meiying BaiDepartment of Gastrointestinal Surgery, Heze Municipal Hospital, No. 2888 Caozhou Road, Heze, 274031, Shandong Province, China.
Ming WangDepartment of Gastrointestinal Surgery, Heze Municipal Hospital, No. 2888 Caozhou Road, Heze, 274031, Shandong Province, China. wangming2010@alumni.sjtu.edu.cn.ORCID http://orcid.org/0009-0003-0926-7473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laparoscopic resection (LR) for T4 colon cancer (CC) remains controversial due to concerns about oncological radicality and the lack of tactile feedback. In their recent propensity score matched study, Jiang et al. provide valuable evidence that LR can achieve comparable short and long term outcomes to open resection (OR) in this challenging subgroup. We highlight several clinically important observations. First, the LR group yielded significantly more harvested lymph nodes than the OR group (18.2 vs. 14.3, P = 0.001), suggesting that magnified visualization may compensate for the absence of palpation and enable adequate mesocolic excision. Second, despite a significantly lower adjuvant chemotherapy rate in the LR group (37.3% vs. 62.7%, P = 0.003), overall and disease free survival were equivalent, which may reflect reduced surgical trauma and better preservation of physiological reserve. Third, the T4b subgroup analysis, although underpowered, showed a trend toward lower recurrence in the LR arm, but these findings require cautious interpretation. The authors appropriately emphasize that LR should be reserved for high volume centres with experienced surgeons, and the exclusion of converted cases underscores the need for rigorous preoperative selection. Overall, this study supports LR as a viable option for selected T4 CC patients. Future multicentre research, possibly incorporating robotic platforms, will be essential to confirm these promising results and refine patient selection criteria.

Indexed as

Laparoscopic surgeryMinimally invasive surgeryOncological outcomesPropensity score matchingT4 colon cancer

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.